High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control

Journal of Diabetes and its Complications

Volumn 16, Issue 5, 2002, Pages 313-320

  Hempe, James M ^a,b   Gomez, Ricardo ^a,b   McCarter Jr , Robert J ^c   Chalew, Stuart A ^a,b  

^a The Research Institute for Children at Children's Hospital New Orleans   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Diabetic complications; Glycated hemoglobin; Glycemic control; HbA1c

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; ERYTHROCYTE LIFESPAN; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SELF MONITORING; STATISTICAL MODEL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; ERYTHROCYTE AGING; ERYTHROCYTES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; PHENOTYPE; REGRESSION ANALYSIS;

EID: 0036741885     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00227-6     Document Type: Article

References (24)

1. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine. 46:1995;223-234.
2. Brownlee M. Negative consequences of glycation. Metabolism: Clinical and Experimental. 49:2000;9-13.
3. Bunn H.F., Shapiro R., McManus M., Garrick L., McDonald M.J., Gallop P.M., Gabbay K.H. Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. Journal of Biological Chemistry. 254:1979;3892-3898.
4. The Diabetes Control and Complications Trial Research Group Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care. 10:1987;1-19.
5. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329:1993;977-986.
6. Friedman E.A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care. 22(Suppl. 2):1999;B65-B71.
7. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M. Tests of glycemia in diabetes. Diabetes Care. 18:1995;896-909.
8. Gould B.J., Davie S.J., Yudkin J.S. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clinica Chimica Acta. 260:1997;49-64.
9. Griffiths W.J., Fitzpatrick M. The effect of age on the creatine in red cells. British Journal of Haematology. 13:1967;175-180.
10. Hempe J.M., Craver R.D. Quantification of hemoglobin variants by capillary isoelectric focusing. Clinical Chemistry. 40:1994;2288-2295.
11. Hempe J.M., Granger J.G., Warrier R.P., Craver R.D. Analysis of hemoglobin variants by capillary isoelectric focusing. Journal of Capillary Electrophoresis. 4:1997;131-135.
12. Hempe J.M., Vargas A., Craver R.D. Clinical analysis of structural hemoglobin variants and HbA1c by capillary isoelectric focusing. Petersen J.R., Mohammad A.A. Clinical and forensic applications of capillary electrophoresis. 2001;145-163 Humana Press, Totowa, NJ.
13. Higgins P.J., Bunn H.F. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. Journal of Biological Chemistry. 256:1981;5204-5208.
14. Hudson P.R., Child D.F., Jones H., Williams C.P. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Annals of Clinical Biochemistry. 36:1999;451-459.
15. Kilpatrick E.S. Problems in the assessment of glycaemic control in diabetes mellitus. Diabetic Medicine. 14:1997;819-831.
16. Kilpatrick E.S., Maylor P.W., Keevil B.G. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care. 21:1998;261-264.
17. Krishnamurti U., Steffes M.W. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clinical Chemistry. 47:2001;1157-1165.
18. Madsen H., Kjaergaard J.J., Ditzel J. Relationship between glycosylation of haemoglobin and the duration of diabetes: a study during the third trimester of pregnancy. Diabetologia. 22:1982;37-40.
19. Murray R.L. Creatine. Pesce A.J., Kaplan L.A. Methods in clinical chemistry. 1987;876-881 CV Mosby, St. Louis, MO.
20. Peterson K.P., Pavlovich J.G., Goldstein D., Little R., England J., Peterson C.M. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clinical Chemistry. 44:1998;1951-1958.
21. Service F.J., O'Brien P.C., Rizza R.A. Measurements of glucose control. Diabetes Care. 10:1987;225-237.
22. Shapiro R., McManus M.J., Zalut C., Bunn H.F. Sites of nonenzymatic glycosylation of human hemoglobin A. Journal of Biological Chemistry. 255:1980;3120-3127.
23. Turner R.C. The UK prospective diabetes study. A review. Diabetes Care. 21(Suppl. 3):1998;C35-C38.
24. Yudkin J.S., Forrest R.D., Jackson C.A., Ryle A.J., Davie S., Gould B.J. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 33:1990;208-215.